MANINI, MATTEO ANGELO
 Distribuzione geografica
Continente #
EU - Europa 1.983
NA - Nord America 1.362
AS - Asia 941
SA - Sud America 90
AF - Africa 25
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.410
Nazione #
US - Stati Uniti d'America 1.308
GB - Regno Unito 967
CN - Cina 399
DE - Germania 266
SG - Singapore 201
IT - Italia 187
SE - Svezia 161
HK - Hong Kong 117
RU - Federazione Russa 85
IN - India 65
BR - Brasile 64
FR - Francia 62
UA - Ucraina 62
CA - Canada 44
IE - Irlanda 44
NL - Olanda 40
KR - Corea 36
TR - Turchia 32
VN - Vietnam 32
FI - Finlandia 31
EU - Europa 23
DK - Danimarca 21
ID - Indonesia 17
CI - Costa d'Avorio 16
CO - Colombia 16
BE - Belgio 12
JP - Giappone 12
GR - Grecia 9
CH - Svizzera 7
UZ - Uzbekistan 7
ES - Italia 6
AR - Argentina 5
AT - Austria 5
AU - Australia 5
MX - Messico 5
RO - Romania 4
IQ - Iraq 3
PL - Polonia 3
BD - Bangladesh 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
EG - Egitto 2
IL - Israele 2
LV - Lettonia 2
MA - Marocco 2
PH - Filippine 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CL - Cile 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
LT - Lituania 1
ML - Mali 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 4.429
Città #
Southend 921
Dallas 158
Chandler 144
Ashburn 134
Singapore 109
Beijing 107
Hong Kong 107
Frankfurt am Main 89
Milan 64
Seattle 59
Princeton 51
Ann Arbor 49
Dublin 44
Wilmington 44
Jacksonville 43
Dearborn 40
New York 33
Fairfield 32
Houston 28
Grafing 27
Nanjing 27
Toronto 27
Council Bluffs 26
Bengaluru 23
Santa Clara 23
Woodbridge 23
Shanghai 22
Redmond 21
Des Moines 20
Mountain View 19
Serra 17
Abidjan 16
Buffalo 16
Boardman 15
Columbus 15
Guangzhou 15
Los Angeles 14
Munich 14
Andover 13
Bogotá 13
Moscow 13
Redwood City 13
Brussels 12
Cambridge 12
Hanoi 12
Helsinki 12
Saint Petersburg 11
Sakarya 11
Hefei 9
Hangzhou 8
Jakarta 8
Somerville 8
Tokyo 8
Berlin 7
Bitonto 7
Fuzhou 7
Nanchang 7
Phoenix 7
Quanzhou 7
Turin 7
Changsha 6
Hebei 6
Ho Chi Minh City 6
Jinan 6
Rome 6
Athens 5
Cangzhou 5
Central District 5
Dong Ket 5
Istanbul 5
Jiaxing 5
Mumbai 5
San Diego 5
Wuhan 5
Kunming 4
London 4
Shenyang 4
Shenzhen 4
Sunnyvale 4
São Paulo 4
The Dalles 4
Auburn Hills 3
Boston 3
Brooklyn 3
Bühl 3
Central 3
Cornate D'adda 3
Delhi 3
Etobicoke 3
Gallo 3
Groningen 3
Hameln 3
Jersey City 3
Medford 3
Ningbo 3
Nuremberg 3
Ottawa 3
Piscataway 3
Roxbury 3
Spring 3
Totale 3.008
Nome #
Glomerular filtration rate: A prognostic marker in atrial fibrillation—A subanalysis of the AntiThrombotic Agents Atrial Fibrillation 523
Experience Wwith Early Sorafenib Treatment with Mtor Inhibitors in Hepatocellular Carcinoma Recurring after Liver Transplantation 319
Early and late de novo tumors after liver transplantation in adults: the late onset of bladder tumors in men 242
Serum expression of lectin reactive alphafetoprotein, des-gamma-carboxy prothrombin, Golgi protein-73 antigen and antibody, for the diagnosis of hepatocellular carcinoma 229
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation 197
Management of Biliary Anastomotic Strictures After Liver Transplantation (BASALT Study): a Nationwide Italian Survey 187
Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis 187
The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis 175
The impact of infection by multidrug resistant agents in patients with cirrhosis : A multicenter prospective study 175
Recist versus easl criteria for the evaluation of HCC response to sorafenib 174
TACE with drug-eluting beads is effective for the maintenance of the milan-in status in patients with a small hepatocellular carcinoma 169
Chemoembolization with epirubicin drug eluting beads to treat early and intermediate hepatocellular carcinoma 165
Characterisation of liver nodules in patients with chronic liver disease by MRI: comparison between the LI-RADS v2014 and the Likert scale 157
Prospective validation of immunohistological stain for glypican-3 (GPC-3) in the early diagnosis of hepatocellular carcinoma 156
Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma 156
The natural history of hepatic macroregenerative nodules developing in cirrhotic patients during surveillance with ultrasound (US) 155
Prospective validation of AASLD guidelines for the early diagnosis of hepatocellular carcinoma in cirrhotic patients 149
The natural history of macroregenerative nodules prospectively detected in cirrhotic patients under surveillance 148
Prospective validation of immunohistological stain for glypican-3 (GPC-3) in the early diagnosis of hepatocellular carcinoma 148
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 141
Prospective evaluation of staging systems for hepatocellular carcinoma detected during surveillance of cirrhotic patients 139
Characterization of liver nodules in patients with chronic liver disease by MRI: performance of the Liver Imaging Reporting and Data System (LI-RADS v.2018) scale and its comparison with the Likert scale 138
Prospective validation of AASLD guidelines for the early diagnosis of hepatocellular carcinoma in cirrhotic patients 135
Twelve week post-treatment undetectable hepatitis C virus (HCV)-RNA by PCR assay predicts a sustained virological response to anti-HCV therapy independently from immunological status of the infected patients 132
Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients : a 5-year follow-up study after hepatitis B immunoglobulin withdrawal 115
Totale 4.611
Categoria #
all - tutte 11.946
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.946


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021394 0 0 0 0 38 46 32 37 77 32 82 50
2021/2022389 40 23 13 39 17 10 23 41 47 55 13 68
2022/2023455 57 62 44 42 46 99 6 26 49 2 18 4
2023/2024322 14 21 21 11 95 9 25 35 18 12 34 27
2024/2025659 32 80 14 69 27 23 17 79 34 78 55 151
2025/2026580 148 83 206 93 50 0 0 0 0 0 0 0
Totale 4.611